Literature DB >> 17050077

Pax-5 expression in nonhematopoietic tissues.

Emina Torlakovic1, Ana Slipicevic, Chris Robinson, John F DeCoteau, G Cecilie Alfsen, Mogens Vyberg, Richa Chibbar, Vivi Ann Flørenes.   

Abstract

We evaluated 123 formalin-fixed, paraffin-embedded samples, including neuroendocrine tumors, adult brain, mesonephric tissues, and from various other sites. A pre-B lymphoma cell line, Daudi, and a small cell carcinoma cell line, NCL-H128, were evaluated by Western blot. All tissues were immunostained by mouse monoclonal anti-Pax-5 antibody by using standard, synthetic polymer-based detection methods. Our study describes for the first time distribution of Pax-5 in adult brain tissue, including periaqueductal gray matter of the midbrain, area postrema of the medulla oblongata, and occasional cells of the spinal trigeminal nucleus (caudal nucleus). We confirm that Pax-5 is expressed regularly in poorly differentiated neuroendocrine tumors but never in well-differentiated classic carcinoid tumors. Pax-5 expression also was found readily in benign and malignant mesonephric tissues and focally in müllerian duct-derived tissues and tumors. Expression of Pax-5 in the Daudi and NCL-H128 cell lines was confirmed by Western blot. Together, these results are important for correct interpretation of results in immunophenotyping of undifferentiated tumors, for diagnosis of mesonephric carcinoma, and, potentially, for correct classification of neuroendocrine tumors in small biopsy samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050077     DOI: 10.1309/XEC7-JMW9-YRM7-4RNO

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

Review 1.  The role of Pax5 in leukemia: diagnosis and prognosis significance.

Authors:  Mohammad Shahjahani; Fatemeh Norozi; Ahmad Ahmadzadeh; Saeid Shahrabi; Farzaneh Tavakoli; Ali Amin Asnafi; Najmaldin Saki
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

2.  PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.

Authors:  Mohamed M Desouki; Ginell R Post; Daniel Cherry; John Lazarchick
Journal:  Clin Med Res       Date:  2010-07

3.  Immunohistochemical expression of PAX5 and TdT by Merkel cell carcinoma and pulmonary small cell carcinoma: a potential diagnostic pitfall but useful discriminatory marker.

Authors:  Ravindra Kolhe; Michelle D Reid; Jeffrey R Lee; Cynthia Cohen; Preetha Ramalingam
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

4.  Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.

Authors:  John A Papalas; Matthew S McKinney; Evan Kulbacki; Sandeep S Dave; Endi Wang
Journal:  Am J Dermatopathol       Date:  2014-02       Impact factor: 1.533

Review 5.  Overview of PAX gene family: analysis of human tissue-specific variant expression and involvement in human disease.

Authors:  Brian Thompson; Emily A Davidson; Wei Liu; Daniel W Nebert; Elspeth A Bruford; Hongyu Zhao; Emmanouil T Dermitzakis; David C Thompson; Vasilis Vasiliou
Journal:  Hum Genet       Date:  2020-07-29       Impact factor: 4.132

6.  Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.

Authors:  Rafael Guerrero-Preston; Christina Michailidi; Luigi Marchionni; Curtis R Pickering; Mitchell J Frederick; Jeffrey N Myers; Srinivasan Yegnasubramanian; Tal Hadar; Maartje G Noordhuis; Veronika Zizkova; Elana Fertig; Nishant Agrawal; William Westra; Wayne Koch; Joseph Califano; Victor E Velculescu; David Sidransky
Journal:  Epigenetics       Date:  2014-05-01       Impact factor: 4.528

7.  Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer.

Authors:  Jingyu Deng; Han Liang; Rupeng Zhang; Qiuping Dong; Yachao Hou; Jun Yu; Daiming Fan; Xishan Hao
Journal:  Oncotarget       Date:  2014-09-15

8.  A case of basal cell carcinoma of the nictitating membrane in a dog.

Authors:  Roxanne M Rodriguez Galarza; Stephanie M Shrader; Jennifer W Koehler; Eva Abarca
Journal:  Clin Case Rep       Date:  2016-10-28

9.  A Unique "Composite" PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant.

Authors:  Kristin La Fortune; Dahua Zhang; Gordana Raca; Erik A Ranheim
Journal:  Case Rep Hematol       Date:  2013-05-07

Review 10.  Pax genes in embryogenesis and oncogenesis.

Authors:  Qiuyu Wang; Wen-Hui Fang; Jerzy Krupinski; Shant Kumar; Mark Slevin; Patricia Kumar
Journal:  J Cell Mol Med       Date:  2008-07-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.